π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The purpose of this study is to determine whether XPro1595 can prevent the ...
Status
Terminated
Location
NEA Baptist
Start Date
2020-10-21
Trial ID
NCT04370236
The goal of this Phase 2 Alzheimer's study is to determine whether 1.0 mg/k...
Status
Completed
Location
INmune Bio Investigational Site
Start Date
2022-02-28
Trial ID
NCT05318976
The goal of this Phase 2 MCI study is to determine whether 1.0 mg/kg XPro15...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-06
Trial ID
NCT05321498
The goal of this Phase 2 Open Label study is to evaluate long-term safety, ...
Status
Terminated
Location
KaRa MINDS
Start Date
2023-02-21
Trial ID
NCT05522387
Treatments Being Tested
The purpose of this study is to evaluate safety and target engagement of XP...
Status
Completed
Location
KaRa MINDS
Start Date
2019-11-20
Trial ID
NCT03943264
Treatments Being Tested